A first-of-its-kind blood test for Alzheimer’s disease is now on sale, signaling a potential breakthrough for patients but also raising concerns. The test from C2N Diagnostics of St. Louis determines if patients have a buildup of a protein called beta-amyloid in the brain, evidence that is key to a dementia diagnosis. Currently, the best way...
